Company Performance - HP's stock closed at $19.43, down 1.12%, underperforming the S&P 500 which gained 0.47% [1] - Over the past month, HP shares have decreased by 8.48%, while the Computer and Technology sector lost 1.96% and the S&P 500 lost 0.16% [1] Upcoming Financial Results - HP is set to announce its earnings on February 24, 2026, with analysts expecting earnings of $0.77 per share, reflecting a year-over-year growth of 4.05% [2] - The revenue forecast for the upcoming quarter is $14.06 billion, indicating a 4.13% growth compared to the same quarter last year [2] Annual Estimates - For the entire year, the Zacks Consensus Estimates predict earnings of $2.97 per share and revenue of $55.16 billion, showing changes of -4.81% and -0.25% respectively compared to the previous year [3] Analyst Estimates and Market Sentiment - Recent modifications to analyst estimates for HP are crucial as they reflect short-term business trends, with positive revisions indicating analyst optimism [4] - The Zacks Rank system, which incorporates estimate changes, currently rates HP at 4 (Sell), with a 0.79% decline in the Zacks Consensus EPS estimate over the past month [6] Valuation Metrics - HP's Forward P/E ratio stands at 6.62, which is below the industry average of 10.78 [7] - The company has a PEG ratio of 0.31, compared to the industry average PEG ratio of 0.61 [8] Industry Context - The Computer - Micro Computers industry, part of the broader Computer and Technology sector, holds a Zacks Industry Rank of 204, placing it in the bottom 17% of over 250 industries [9]

Moderna (MRNA) closed at $41.95 in the latest trading session, marking a +2.29% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.47%. Meanwhile, the Dow experienced a rise of 0.04%, and the technology-dominated Nasdaq saw an increase of 0.9%. Coming into today, shares of the biotechnology company had gained 19.56% in the past month. In that same time, the Medical sector gained 2.92%, while the S&P 500 lost 0.16%. Investors will be eagerly watching for the performance o ...

分组1 - Kilroy Realty (KRC) reported quarterly funds from operations (FFO) of $0.97 per share, missing the Zacks Consensus Estimate of $0.98 per share, and down from $1.2 per share a year ago, representing an FFO surprise of -1.12% [1] - The company posted revenues of $272.19 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.58%, but down from year-ago revenues of $286.38 million [2] - Kilroy Realty shares have underperformed the market, losing about 6.3% since the beginning of the year compared to the S&P 500's gain of 1.3% [3] 分组2 - The current consensus FFO estimate for the coming quarter is $0.88 on revenues of $269.06 million, and for the current fiscal year, it is $3.36 on revenues of $1.08 billion [7] - The Zacks Industry Rank for REIT and Equity Trust - Other is currently in the bottom 25% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

分组1 - UDR reported quarterly funds from operations (FFO) of $0.64 per share, matching the Zacks Consensus Estimate, and showing a year-over-year increase from $0.63 per share [1] - The company posted revenues of $428.83 million for the quarter ended December 2025, which was a slight miss against the Zacks Consensus Estimate by 0.16%, compared to $420.44 million in the same quarter last year [2] - UDR has surpassed consensus FFO estimates two times over the last four quarters, while it has only topped consensus revenue estimates once in the same period [2] 分组2 - The stock has gained approximately 2.4% since the beginning of the year, outperforming the S&P 500's gain of 1.3% [3] - The current consensus FFO estimate for the upcoming quarter is $0.63, with projected revenues of $430.54 million, and for the current fiscal year, the estimate is $2.56 on revenues of $1.75 billion [7] - The Zacks Industry Rank for REIT and Equity Trust - Residential is currently in the bottom 36% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

分组1 - Brixmor Property (BRX) reported quarterly funds from operations (FFO) of $0.58 per share, exceeding the Zacks Consensus Estimate of $0.57 per share, and up from $0.53 per share a year ago, representing an FFO surprise of +2.33% [1] - The company achieved revenues of $353.75 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.59%, compared to year-ago revenues of $328.44 million [2] - Brixmor has outperformed the S&P 500 with an 8% increase in shares since the beginning of the year, while the S&P 500 gained 1.3% [3] 分组2 - The future performance of Brixmor's stock will largely depend on management's commentary during the earnings call and the company's FFO outlook for upcoming quarters [3][4] - The current consensus FFO estimate for the next quarter is $0.58 on revenues of $347.77 million, and for the current fiscal year, it is $2.35 on revenues of $1.42 billion [7] - The REIT and Equity Trust - Retail industry, to which Brixmor belongs, is currently ranked in the top 32% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8]

Core Insights - The Q4 earnings season for 2025 has been positive, with strong growth and many companies exceeding expectations, except for NVIDIA [1] Boot Barn (BOOT) - Boot Barn reported a 16% year-over-year increase in sales, with same-store sales rising by 5.7%, indicating strong performance in existing stores while expanding [2][4] - The company opened 25 new locations, bringing the total to 514, and achieved a gross margin of 39.9%, up from 39.3% year-over-year, reflecting improved profitability [4][6] - Boot Barn anticipates opening 70 new stores in FY26, with projected sales between $2.24 billion and $2.25 billion, and same-store sales growth expected to be between 6.5% and 7.5% [8] Cardinal Health (CAH) - Cardinal Health experienced an 18.8% year-over-year sales increase and a 36.3% growth in adjusted EPS, marking a significant recovery after stagnation in 2024 [9][12] - Sales growth was broad-based, with Pharmaceuticals and Specialty Solutions up 19% year-over-year, contributing approximately 90% of total sales [12] - The company raised its FY26 outlook for adjusted EPS to a range of $10.15 to $10.35, suggesting a 24.5% year-over-year growth [14] Overall Market Sentiment - Both Boot Barn and Cardinal Health have raised their guidance following strong quarterly results, indicating potential near-term outperformance [16]

FormFactor (FORM) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this integrated circuits diagnostic company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in ear ...

Core Viewpoint - Plexus (PLXS) is positioned as a strong investment opportunity due to significant upward revisions in earnings estimates, indicating a positive earnings outlook that may continue to drive stock performance [1][11]. Earnings Estimate Revisions - Analysts have shown growing optimism regarding Plexus's earnings prospects, reflected in the upward trend of estimate revisions, which historically correlates with stock price movements [2]. - The current-quarter earnings estimate for Plexus is projected at $1.85 per share, representing an 11.5% year-over-year increase, with a 13.54% rise in consensus estimates over the last 30 days [7]. - For the full year, the earnings estimate stands at $7.61 per share, reflecting a 2.4% increase from the previous year, with a 5.27% boost in consensus estimates during the same timeframe [8][9]. Zacks Rank and Performance - Plexus currently holds a Zacks Rank 1 (Strong Buy), supported by strong agreement among analysts on upward earnings revisions, which historically leads to significant outperformance [3][10]. - Stocks rated Zacks Rank 1 have generated an average annual return of +25% since 2008, indicating a robust track record of success [3]. Stock Performance - Plexus has experienced a notable 30.8% gain over the past four weeks, driven by solid estimate revisions and positive earnings growth prospects, suggesting it may be a timely addition to investment portfolios [11].

Core Insights - Auna S.A. has a strong history of beating earnings estimates, with an average surprise of 93.59% over the last two quarters, indicating potential for continued performance in upcoming reports [1][2] Earnings Performance - For the last reported quarter, Auna S.A. achieved earnings of $0.20 per share, exceeding the Zacks Consensus Estimate of $0.15 per share by 33.33% [2] - In the previous quarter, the company reported earnings of $0.33 per share against an expected $0.13 per share, resulting in a surprise of 153.85% [2] Earnings Estimates - Recent estimates for Auna S.A. have been trending upward, with a positive Earnings ESP of +44.00%, suggesting increased analyst optimism regarding the company's near-term earnings potential [5][8] - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) indicates a strong likelihood of another earnings beat [5][8] Predictive Metrics - Stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have historically produced positive surprises nearly 70% of the time, indicating a high probability of exceeding consensus estimates [6] - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions and potentially more accurate predictions [7]

Core Viewpoint - Middlefield Banc Corp. (MBCN) is positioned well to potentially beat earnings estimates in its upcoming quarterly report, supported by a strong history of exceeding expectations [1]. Earnings Performance - Middlefield Banc has a solid track record of surpassing earnings estimates, with an average surprise of 17.45% over the last two quarters [2]. - In the most recent quarter, the company reported earnings of $0.65 per share against an expectation of $0.64, resulting in a surprise of 1.56% [2]. - For the previous quarter, the consensus estimate was $0.57 per share, while the actual earnings were $0.76 per share, leading to a surprise of 33.33% [2]. Earnings Estimates and Predictions - Estimates for Middlefield Banc have been trending upward, influenced by its history of earnings surprises [5]. - The company currently has a positive Zacks Earnings ESP of +1.54%, indicating that analysts are optimistic about its earnings prospects [8]. - The combination of a positive Earnings ESP and a Zacks Rank of 3 (Hold) suggests a strong possibility of another earnings beat [8]. Statistical Insights - Research indicates that stocks with a positive Earnings ESP and a Zacks Rank of 3 or better have a nearly 70% chance of producing a positive surprise [6]. - The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate, reflecting the latest analyst revisions [7]. Importance of Earnings ESP - It is crucial for investors to check a company's Earnings ESP prior to its quarterly release to enhance the likelihood of successful investment decisions [10].